Unraveling the Complexities of Science to Inform Business Strategy
We've been told by customers that our software is an "Opportunity Engine". Our CI landscaping methodologies expose opportunities and challenges in the life sciences that drive action and help you win marketshare. Understanding who your competitors are and the technologies and disease spaces they are working in, will inform your strategy for revenue growth. Executives use our software to benchmark their organization's innovation performance against their competition.
Identify & Scout Emerging Technologies
MavenVue's advanced analytics and data mining capabilities reveal how cutting-edge technologies are being applied in the medicine and beyond. Current information pulled from terabytes of data are presented to you quickly and comprehensibly to keep you abreast of the latest innovations coming out of research labs globally forecasting trends that inform decisions around investments, licensing, acquisitions, and research dollars.
Life Science Intelligence
You do not have to be a Domain Expert in all things Life Science to use our application because we have designed the product "to push" information as opposed to requiring you "to pull" information out. We've spent our time developing analytics behind your screen, so that you can quickly discover connections across disparate data sets. Uncovering relationships between diseases, genes, chemicals, drugs, trials, and organizations is now a fast and insightful experience, because we want you to spend your time finding cures, developing devices and building businesses that save lives.
IP assets sitting on a shelf is a sad situation for everyone --for the inventors and the commercial world that may never know about the IP. We want to help inventors monetize and commercialize their IP by giving them prior art searching capabilities and insight into potential partners or investors. On the flip side, MavenVue's software helps organizations and investors find IP assets, inventors and start-ups looking for partners or cash. Our mission is to drive research to commercialization and benefits to end-users.